Forbes

It’s expected that 2027 will see the largest spike in recent memory of the numbers of un- and underinsured individuals in the United States.

Orexin reveals how a small brain peptide controls wakefulness, explains narcolepsy, and inspires new treatments—and a search for the genome’s hidden proteins.

The Big 12 admitted a clock error ended BYU vs. Notre Dame football game early. A neurosurgeon discusses how surgical timeouts can be applied to improve the process.

Government policies and private-market incentives reward hospital-physician consolidation and increase healthcare costs. Insurers are pushing back, but face limits.

Washington is loosening oversight of clinical AI while California and other states are writing their own rules. A physician explains what may happen next for clinical AI.

Healthcare organizations have long relied on incremental adjustments that failed to resolve the affordability crisis. New economic forces require a different strategy.

Bloomberg Philanthropies and Vision To Learn just announced a new $8.4 million investment into expanding school-based vision care for children in the U.S.

Trump has publicly slammed pharma and health insurers for their alleged profiteering off the backs of patients. But his administration’s policies have had little impact.

A public health expert explains what you need to know about rising flu cases and how you and your loved ones can stay protected.

Study finds that psychotherapy during pregnancy can improve depression outcomes and could benefit infant brain and emotional development.

More December games could expose players and fans to dangerous cold, while an earlier season start could increase heat risks. Here's what's at stake.

Gene therapy cut severe infections 93% in Wiskott-Aldrich syndrome, using patients’ own modified stem cells to treat a rare inherited immune disorder.

A simple but effective way to reduce firearm-related deaths is by promoting safe storage of guns in the home and other practical, evidence-based strategies.

CEO Dave Ricks built Eli Lilly into the first $1 trillion pharma company with its blockbuster weight-loss and diabetes drugs. But with more than 60% of revenue coming from them, the drug giant faces the risks of its own success.

Your immune cells are constantly aging. Cellino is launching a new service, called Reservoir, to let people securely store them from a simple blood draw for $5,000.